Business Context and Reporting Period
This Form 8-K Current Report was filed by Palisade Bio, Inc. on May 3, 2022. The filing serves as a Regulation FD disclosure regarding the release of a revised corporate presentation made available on the company's website.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate presentation rather than a financial statement.
Material Changes
The material event reported is the release of a revised corporate presentation. The filing explicitly states that the information contained in the presentation is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings unless specifically stated by the Company.
Guidance, Outlook, and Risks
While the filing references a revised corporate presentation which likely contains outlook and management commentary, the text of this 8-K does not summarize the specific guidance, risks, or contingencies contained within that presentation. Investors must refer to the attached Exhibit 99.1 for those details.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation) for specific financial projections and strategic updates.
- Confirm that the revised presentation has been accessed via the company's official website.
- Note that the content of the presentation is not legally incorporated by reference into this filing.
- Verify the trading symbol PALI on the Nasdaq Capital Market for current stock performance.